Jefferies upgraded Oscar Health from Underperform to Hold and set a new price target of $16.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/20/2026 | $16.00 | Underperform → Hold | Jefferies |
| 2/12/2026 | $18.00 | Mkt Perform → Outperform | Raymond James |
| 1/9/2026 | $17.00 | Sell → Neutral | UBS |
| 1/5/2026 | $18.00 | Underweight → Equal Weight | Barclays |
| 12/11/2025 | $17.00 | Equal-Weight | Stephens |
| 11/26/2025 | $25.00 | Neutral → Overweight | Piper Sandler |
| 10/14/2025 | $17.00 | Neutral | Goldman |
| 7/25/2025 | $14.00 | Outperform → Neutral | Robert W. Baird |
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced the appointment of independent director Siddhartha Sankaran as Chair of the Board, effective June 4, 2026. Sankaran will succeed Jeffery Boyd, who has served as Chair since February 2021 and is not standing for reelection at Oscar Health's Annual Meeting. Sankaran has more than 20 years of leadership in the insurance industry, serving in executive roles at multiple public companies, including at American International Group, Inc., SiriusPoint Ltd. and FWD Group Holdings Limited. He brings a wealth of expertise from serving on numerous boards. He also contributed to building
Oscar Health, Inc. (NYSE:OSCR) today launched Lucie Health Marketplace, a new all-in-one storefront that begins to change how America shops for healthcare. Lucie connects consumers and brokers to every major individual market plan and a curated menu of ancillary and supplemental products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420960234/en/ Consumers buy cars, homes, and everyday products with transparency and choice. Healthcare is next. Lucie's platform can serve millions of entrepreneurs, full- and part-time employees, gig workers, and early retirees. "Employer healthcare looks good on paper but fails the moment m
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2026 financial results before the market opens on Wednesday, May 6, 2026. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following May 6, 2026 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentl
8-K - Oscar Health, Inc. (0001568651) (Filer)
SCHEDULE 13G/A - Oscar Health, Inc. (0001568651) (Subject)
144 - Oscar Health, Inc. (0001568651) (Subject)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
Jefferies upgraded Oscar Health from Underperform to Hold and set a new price target of $16.00
Raymond James upgraded Oscar Health from Mkt Perform to Outperform and set a new price target of $18.00
UBS upgraded Oscar Health from Sell to Neutral and set a new price target of $17.00
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced the appointment of independent director Siddhartha Sankaran as Chair of the Board, effective June 4, 2026. Sankaran will succeed Jeffery Boyd, who has served as Chair since February 2021 and is not standing for reelection at Oscar Health's Annual Meeting. Sankaran has more than 20 years of leadership in the insurance industry, serving in executive roles at multiple public companies, including at American International Group, Inc., SiriusPoint Ltd. and FWD Group Holdings Limited. He brings a wealth of expertise from serving on numerous boards. He also contributed to building
DRAPER, Utah, March 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that William ‘Bill' Gassen, president and chief executive officer of Sanford Health, has been elected to its board of directors (the "Board") effective March 26, 2026. He will also serve on the Audit and Risk Committee and Talent, Compensation and Culture Committee of the Board. His appointment expands the Board to 10 directors, eight of whom are independent. "Bill brings deep insight into how care is delivered, how it is financed
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment. The awards were granted under Oscar's 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G - Oscar Health, Inc. (0001568651) (Subject)
SC 13D/A - Oscar Health, Inc. (0001568651) (Subject)
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2026 financial results before the market opens on Wednesday, May 6, 2026. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following May 6, 2026 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentl
Achieves Record Membership of ~3.4 Million and Provides Full-Year 2026 Outlook Including More Than $18 Billion in Revenue Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026," said Mark Bertolini, CEO of Oscar Health. "Our new suite of affordable products, agentic AI features, and exceptional member experience drove record-high membership – positioning us to achieve significantly improved financial performance in 2026. Oscar's growth demonstrates consumers vote where the
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2025 financial results before the market opens on Tuesday, February 10, 2026. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following February 10, 2026 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack techno